Skip to main content

Text / Kenneth Cohen: interview

Have a question about this item?

Item information. View source record on contributor's website.

Title
Kenneth Cohen: interview
Creator
UC San Diego
Contributor
Cohen, Kenneth
Shindell, Matthew
Date Created and/or Issued
Recorded August 5, 2008
Contributing Institution
UC San Diego, Special Collections and Archives
Collection
San Diego Technology Archive Oral Histories
Rights Information
Under copyright
Constraint(s) on Use: This work is protected by the U.S. Copyright Law (Title 17, U.S.C.). Use of this work beyond that allowed by "fair use" requires written permission of the UC Regents. Responsibility for obtaining permissions and any use and distribution of this work rests exclusively with the user and not the UC San Diego Library. Inquiries can be made to the UC San Diego Library program having custody of the work.
Use: This work is available from the UC San Diego Library. This digital copy of the work is intended to support research, teaching, and private study.
Rights Holder and Contact
UC Regents
Description
Mr. Cohen received degrees in biology and chemistry from Dartmouth College and an MBA from the Wharton School of The University of Pennsylvania. Mr. Cohen began his career at Eli Lilly and Company in 1978, where, among many different responsibilities over ten years, he directed business planning for the Medical Instrument Systems Division (now known as Guidant Corporation) and managed the launch of Prozac. Subsequently, Mr. Cohen served as Vice President of Business Affairs at Argus Pharmaceuticals, Inc., Vice President of Marketing and Business development for LifeCell Corporation, Executive Vice President and Chief Operating Officer for Canji Incorporated, and President and Chief Executive Officer of Synbiotics Corporation. In August 2003, Mr. Cohen co-founded Somaxon Pharmaceuticals, Inc. and served as President, Chief Executive Officer and a member of the Board of Directors.
Born digital
Special Collections & Archives, UC San Diego, La Jolla, 92093-0175 (https://lib.ucsd.edu/sca)
At the time of this interview, Mr. Cohen had recently left his position as President and Chief Executive Officer of Somaxon Pharmaceuticals, Inc.
Cohen, Kenneth. Interview conducted by Matthew Shindell, August 5, 2008. The San Diego Technology Archive (SDTA), UC San Diego Library, La Jolla, CA.
Type
text
Identifier
ark:/20775/bb20164662
Subject
Pharmaceutical industry
Fluoxetin
Recombinant human insulin
Fluoxetine
Synbiotics Corporation
Eli Lilly and company
Somaxon Pharmaceuticals, Inc
Guidant Corporation
Argus Pharmaceuticals, Inc
Canji, Inc
San Diego (Calif.)
Place
San Diego (Calif.)

About the collections in Calisphere

Learn more about the collections in Calisphere. View our statement on digital primary resources.

Copyright, permissions, and use

If you're wondering about permissions and what you can do with this item, a good starting point is the "rights information" on this page. See our terms of use for more tips.

Share your story

Has Calisphere helped you advance your research, complete a project, or find something meaningful? We'd love to hear about it; please send us a message.

Explore related content on Calisphere: